drugset / Trial / NCT02322346

Peritonsillar Infiltration With Levobupivacaine for Posttonsillectomy Pain

NCT02322346

Phase 4 Completed 70 enrolled Ankara University
RandomizedCrossoverTriple-blindTreatment

Summary

The investigators aimed to evaluate the effects of different concentrations of preincisional peritonsillar levobupivacaine (0.25% ve 0.5%) on postoperative pain and bleeding

Timeline

Start
2008-08
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified 0.25 % Other
Subject Levobupivacaine Other / unclassified 0.5 % Other

Indications

No indication recorded.